Advertisement
Demo

Catalyst Pharma sees net price of drug, once free, topping $300,000

Feb 12, 2019 , Reuters
Catalyst Pharmaceuticals Inc said on Monday that it expects its drug for a rare disease, which had long been available to patients for free, will cost more than $300,000 per year including rebates to insurers and other discounts.


Read the full story...


Trending healthcare news keywords at this moment

mental fda cancer drug kids cdc outbreak disease test digital marketing media years life care study tip blood state bill medical healthcare launches salmonella states people finds linked age buy measles cases higher risk therapy sleep good diabetes opioid patients heart children york generic food raises doctors